Skip to main content
58°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Allurion Technologies, Inc.
< Previous
1
2
Next >
Allurion Announces Launch of Offering of Common Stock and Warrants
June 26, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
June 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
June 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
June 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
May 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
May 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
May 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
May 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Preliminary First Quarter 2024 Results
April 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
April 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
January 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
January 23, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
January 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
January 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
January 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
January 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
January 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Participate in the Jefferies London Healthcare Conference
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
October 11, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023
October 04, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Tickers
ALUR
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.